Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Beckman, Joshua A ^a   Goldfine, Allison B ^a   Gordon, Mary Beth ^a   Garrett, Leslie A ^a   Keaney Jr , John F ^b   Creager, Mark A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endothelium; Nitric oxide

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID;

ADULT; AGED; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0345303816     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00403.2003     Document Type: Article

References (57)

1. Abou-Seif MA and Youssef AA. Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin Chem 39: 618-623, 2001.
2. Beckman JA, Creager MA, and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-2581, 2002.
3. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA. Apparent hydroxyl radical production by peroxynitirite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
4. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
5. Cinaz P, Hasanoglu A, Bideci A, and Biberoglu G. Plasma and erythrocyte vitamin E levels in children with insulin-dependent diabetes mellitus. J Pediatr Endocrinol Metab 12: 193-196, 1999.
6. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, Yue DK, Betteridge J, and Deanfield JE. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 28: 573-579, 1996.
7. Collins R. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 23-33, 2002.
8. Cosentino F, Hishikawa K, Katusic ZS, and Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28, 1997.
9. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, and Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999.
10. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, and Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000.
11. 2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem 47: 1974-1979, 2001.
12. Diwadkar VA, Anderson JW, Bridges SR, Gowri MS, and Oelgten PR. Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. Proc Soc Exp Biol Med 222: 178-184, 1999.
13. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, and Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259, 1999.
14. Frei B, England L, and Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989.
15. Gazis A, White DJ, Page SR, and Cockcroft JR. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 16: 304-311, 1999.
16. GISSI-Prevenzion Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447-455, 1999. [Erratum. Lancet Feb 24, 357: 642, 2001.]
17. GISSI-Prevenzion Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447-455, 1999. [Erratum. Lancet Feb 24, 357: 642, 2001.]
18. Gotoh N and Niki E. Rates of interactions of superoxide with vitamin E, vitamin C and related compounds as measured by chemiluminescence. Biochim Biophys Acta 1115: 201-207, 1992.
19. Graier WF, Grubenthal I, Dittrich P, Wascher TC, and Kostner GM. Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol 294: 221-229, 1995.
20. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, and Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
21. Heitzer T, Schlinzig T, Krohn K, Meinertz T, and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678, 2001.
22. Heller R, Munscher-Paulig F, Grabner R, and Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274: 8254-8260, 1999.
23. Hink U, Li H, Mollnau H, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Oelze M, Forstermann U, and Munzel T. Effects of diabetes mellitus on nitric oxide synthase (NOSIII) expression, NOS III mediated superoxide production and vascular nitric oxide bioavailability. Circulation 100: 1-235, 1999.
24. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.
25. Huang A, Vita JA, Venema RC, and Keaney JF Jr. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275: 17399-17406, 2000.
26. Jackson TS, Xu A, Vita JA, and Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83: 916-922, 1998.
27. Jialal I, Fuller CJ, and Huet BA. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 15: 190-198, 1995.
28. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, and Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516, 1993.
29. Krempf M, Ranganathan S, Ritz P, Morin M, and Charbonnel B. Plasma vitamin A and E in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) adult diabetic patients. Int J Vitam Nutr Res 61: 38-42, 1991.
30. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
31. Lee IK, Koya D, Ishi H, Kanoh H, and King GL. D-α-Tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res Clin Pract 45: 183-190, 1999.
32. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, and Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93: 3704-3709, 1996.
33. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, and Creager MA. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 78: 1210-1214, 1996.
34. Liu JF and Lee YW. Vitamin C supplementation restores the impaired vitamin E status of guinea pigs fed oxidized frying oil. J Nutr 128: 116-122, 1998.
35. Liu S, Beckman JS, and Ku DD. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Exp Ther 268: 1114-1121, 1994.
36. + channel activity in smooth muscle of human coronary arterioles. Circ Res 91: 1070-1076, 2002.
37. Lundman P, Tornvall P, Nilsson L, and Pernow J. A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis 159: 35-41, 2001.
38. Lynch SM and Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta 1345: 215-221, 1997.
39. Manuel y Keenoy B, Shen H, Engelen W, Vertommen J, Van Dessel G, Lagrou A, and De Leeuw I. Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitus. J Nutr 131: 1723-1730, 2001.
40. Martin A and Frei B. Both intracellular and extracellular vitamin C inhibit atheorsgenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol 17: 1583-1590, 1997.
41. Meraji S, Jayakody L, Senaratne MP, Thomson AB, and Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 36: 978-981, 1987.
42. Milstien S and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681-684, 1999.
43. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, and Draznin B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277: 1794-1799, 2002.
44. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
45. Paolisso G, Tagliamonte MR, Barbieri M, Zito GA, Gambardella A, Varricchio G, Ragno E, and Varricchio M. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 85: 109-115, 2000.,
46. - imbalance in insulin-resistant rat aorta. Diabetes 48: 2437-2445, 1999.
47. Shwaery GT, Vita JA, and Keaney JF Jr. Antioxidant protection of LDL by physiological concentrations of 17 beta-estradiol. Requirement for estradiol modification. Circulation 95: 1378-1385, 1997.
48. Sinclair AJ, Taylor PB, Lunec J, Girling AJ, and Barnett AH. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med 11: 893-898, 1994.
49. Skyrme-Jones RA, O'Brien RC, Berry KL, and Meredith IT. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 36: 94-102, 2000.
50. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, and Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287: 1420-1426, 2002.
51. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, and Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31: 552-557, 1998.
52. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, and Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97: 22-28, 1996.
53. Wang W and Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 233: 748-751, 1997.
54. Williams SB, Cusco JA, Roddy MA, Johnstone MT, and Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27: 567-574, 1996.
55. Wilson JX, Dixon SJ, Yu J, Nees S, and Tyml K. Ascorbate uptake by microvascular endothelial cells of rat skeletal muscle. Microcirculation 3: 211-221, 1996.
56. Yusuf S, Dagenais G, Pogue J, Bosch J, and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 154-160, 2000.
57. Zou M, Yesilkaya A, and Ullrich V. Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration. Drug Metab Rev 31: 343-349, 1999.